Fredun Pharmaceuticals standalone net profit rises 127.87% in the September 2025 quarter
Sales rise 34.33% to Rs 143.59 crore
Net profit of Fredun Pharmaceuticals rose 127.87% to Rs 9.73 crore in the quarter ended September 2025 as against Rs 4.27 crore during the previous quarter ended September 2024. Sales rose 34.33% to Rs 143.59 crore in the quarter ended September 2025 as against Rs 106.89 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales143.59106.89 34 OPM %15.5513.04 -PBDT14.608.63 69 PBT13.007.57 72 NP9.734.27 128Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 10 2025 | 8:20 AM IST